Virtu Financial LLC 9 Meters Biopharma, Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.21 - $0.32 $9,788 - $14,915	46,612 Added 25.61%	228,595 $49,000
Q2 2022 Aug 09, 2022	BUY	$0.26 - $0.64 $47,315 - $116,469	181,983 New	181,983 $47,000
Q1 2022 May 17, 2022	SELL	$0.52 - $1.0 $57,441 - $110,465	-110,465 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.85 - $1.33 $83,861 - $131,217	98,660 Added 835.75%	110,465 $108,000
Q3 2021 Nov 12, 2021	SELL	$1.03 - $1.41 $161,624 - $221,252	-156,917 Reduced 93.0%	11,805 $15,000
Q2 2021 Sep 17, 2021	BUY	$1.04 - $1.5 $52,240 - $75,346	50,231 Added 42.39%	168,722 $186,000
Q1 2021 May 19, 2021	BUY	$0.84 - $2.16 $99,532 - $255,940	118,491 New	118,491 $139,000
Q4 2020 Feb 24, 2021	SELL	$0.65 - $1.11 $24,688 - $42,160	-37,982 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$0.48 - $0.84 $18,231 - $31,904	37,982 New	37,982 $31,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.